scholarly journals Total and ionized serum magnesium and calcium levels during magnesium sulfate administration for preterm labor

2018 ◽  
Vol 61 (1) ◽  
pp. 56 ◽  
Author(s):  
Won Hee Kim ◽  
Yoon Ha Kim ◽  
Yuna An ◽  
Jong Ho Moon ◽  
Eun Ji Noh ◽  
...  
Keyword(s):  
Magnesium Sulfate ◽  
Preterm Labor ◽  
Serum Magnesium

Adverse maternal and neonatal outcome of prolonged magnesium sulfate treatment for preterm labor

2004 ◽  
Vol 191 (6) ◽  
pp. S111
Author(s):  
Anwar Nassar ◽  
Khaled Sakhel ◽  
Hoda Maarouf ◽  
George Naasan ◽  
Ihab Usta
Keyword(s):  
Magnesium Sulfate ◽  
Preterm Labor ◽  
Neonatal Outcome

Premature birth (Clinical lecture)

2018 ◽  
pp. 9-12
Author(s):  
I.B. Ventskovskaya ◽  
◽  
V.V. Bila ◽  
O.S. Countryside ◽  
◽  
...  
Keyword(s):  
Magnesium Sulfate ◽  
Key Words ◽  
Gestational Age ◽  
Evidence Based Medicine ◽  
Premature Birth ◽  
Preterm Labor ◽  
Evidence Based ◽  
Advantages And Disadvantages ◽  
Based Medicine ◽  
Tocolytic Agents

The article presents modern views on the pathogenesis of preterm labor, their relevance and classification. From the perspective of evidence-based medicine methods of prevention are considered. A comparison of the main tocolytic agents, their advantages and disadvantages is presented. Key words: premature birth, perinatal and infantile mortality, tocolysis, magnesium sulfate, gestational age.

scholarly journals 872: A comparison of Ritodrine and Magnesium sulfate for preterm labor: a randomized clinical trial

2020 ◽  
Vol 222 (1) ◽  
pp. S545
Author(s):  
Young Mi Jung ◽  
Seung Mi Lee ◽  
Sun Min Kim ◽  
Byoung Jae Kim ◽  
Seokyung Han ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Magnesium Sulfate ◽  
Randomized Clinical Trial ◽  
Preterm Labor

Factors affecting maternal serum magnesium levels during long-term magnesium sulfate tocolysis in singleton and twin pregnancy

2015 ◽  
Vol 41 (8) ◽  
pp. 1178-1184 ◽  
Author(s):  
Hiroshi Nakazawa ◽  
Akiko Uchida ◽  
Tomoyuki Minamitani ◽  
Aya Makishi ◽  
Yukou Takamatsu ◽  
...  
Keyword(s):  
Magnesium Sulfate ◽  
Twin Pregnancy ◽  
Serum Magnesium ◽  
Maternal Serum ◽  
Factors Affecting

scholarly journals The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Kameron Bechler ◽  
Kristina Shkirkova ◽  
Jeffrey L. Saver ◽  
Sidney Starkman ◽  
Scott Hamilton ◽  
...  
Keyword(s):  
Adverse Events ◽  
Acute Stroke ◽  
Magnesium Sulfate ◽  
Serum Magnesium ◽  
High Dose ◽  
Stroke Patients ◽  
Serious Adverse Events ◽  
Intravenous Magnesium ◽  
Prophylactic Measures ◽  
Cardiac Adverse Events

Background. Cardiac adverse events are common among patients presenting with acute stroke and contribute to overall morbidity and mortality. Prophylactic measures for the reduction of cardiac adverse events in hospitalized stroke patients have not been well understood. We sought to investigate the effect of early initiation of high-dose intravenous magnesium sulfate on cardiac adverse events in stroke patients. Methods. This is a secondary analysis of the prehospital Field Administration of Stroke Therapy-Magnesium (FAST-MAG) randomized phase-3 clinical trial, conducted from 2005-2013. Consecutive patients with suspected acute stroke and a serum magnesium level within 72 hours of enrollment were selected. Twenty grams of magnesium sulfate or placebo was administered in the ambulance starting with a 15-minute loading dose intravenous infusion followed by a 24-hour maintenance infusion in the hospital. Results. Among 1126 patients included in the analysis of this study, 809 (71.8%) patients had ischemic stroke, 277 (24.6%) had hemorrhagic stroke, and 39 (3.5%) with stroke mimics. The mean age was 69.5 (SD13.4) and 42% were female. 565 (50.2%) received magnesium treatment, and 561 (49.8%) received placebo. 254 (22.6%) patients achieved the target, and 872 (77.4%) did not achieve the target, regardless of their treatment group. Among 1126 patients, 159 (14.1%) had at least one CAE. Treatment with magnesium was not associated with fewer cardiac adverse events. A multivariate binary logistic regression for predictors of CAEs showed a positive association of older age and frequency of CAEs (R=1.04, 95% CI 1.03-1.06, p<0.0001). Measures of early and 90-day outcomes did not differ significantly between the magnesium and placebo groups among patients who had CAEs. Conclusion. Treatment of acute stroke patients with magnesium did not result in a reduction in the number or severity of cardiac serious adverse events.

Randomized Comparison of Intravenous Nitroglycerin and Magnesium Sulfate for Treatment of Preterm Labor

1999 ◽  
Vol 19 (2) ◽  
pp. 78-85
Author(s):  
Y. Y. El-Sayed ◽  
E. T. Riley ◽  
R. H. Holbrook ◽  
S. E. Cohen ◽  
U. Chitkara ◽  
...  
Keyword(s):  
Magnesium Sulfate ◽  
Preterm Labor ◽  
Intravenous Nitroglycerin
Sign in / Sign up

Export Citation Format

Share Document